Efficacy of Testosterone Suppression with Sustained-Release Triptorelin in Advanced Prostate Cancer

INTRODUCTION: Androgen deprivation therapy (ADT) is a mainstay of treatment against advanced prostate cancer (PC). As a treatment goal, suppression of plasma testosterone levels to <50 ng/dl has been established over decades. Evidence is growing though that suppression to even lower levels may ad...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Adv Ther
Auteurs principaux: Breul, Jürgen, Lundström, Eija, Purcea, Daniela, Venetz, Werner P., Cabri, Patrick, Dutailly, Pascale, Goldfischer, Evan R.
Format: Artigo
Langue:Inglês
Publié: Springer Healthcare 2016
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5331090/
https://ncbi.nlm.nih.gov/pubmed/28028737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-016-0466-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires